Generalised Anxiety Disorder

2

Review clinical trials related to Generalised Anxiety Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CBT and the Neural Circuits of Anxiety

This study will aim to test whether specific neural circuitry changes, proposed on the basis of a neurocognitive model of anxiety, are a mechanism of action for Cognitive Behavioural Therapy (CBT) interventions. This study aims to provide a theoretical model of the neurobiological mechanisms of CBT's therapeutic effect, where there currently is none, and potentially allow for more targeted/specific approaches to anxiety disorders following the identification of key CBT mechanisms. The ultimate aim is to improve the efficacy of CBT, and more generally, psychological interventions for anxiety disorders.

Participants needed: 174
Trial details
Age: 18-64Biological sex: AllType: ObservationalSponsor: UCLH/UCL Joint Research OfficeUpdated: Jun 29, 2025Locations: 1
Eligibility criteria

Enrolled in IAPT Step 3 (high intensity service) [+2]

Score above 22 on the GAD-7 [+5]

Status: Recruiting

A Neuro-Technological Intervention for Adolescents With GAD

This study aims to evaluate the safety and acceptability of a basic neuro-technological intervention in the treatment of adolescents with Generalised Anxiety Disorder (GAD). Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro- / bio-feedback-based virtual reality (VR) game interface that is driven by a novel algorithm.

Participants needed: 30
Trial details
Age: 13-18Biological sex: AllType: InterventionalSponsor: National Healthcare Group, SingaporeUpdated: May 22, 2025Locations: 1
Eligibility criteria

Between 13 to 18 years of age inclusive [+4]

Diagnosis (as defined by DSM-5) of: anxiety disorder induced by medication, subs... [+6]